Red light cap for scar-forming hair loss in women
Part of Skin clinical trials.
This pilot study tests an “all LED” red light cap to treat central centrifugal cicatricial alopecia (CCCA), a type of scarring hair loss. If you’re a woman with confirmed CCCA at Stage II–III and stable treatment, the study may help see whether red light can improve your hair loss without changing your current plan.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be a woman (18 years or older)
- Have a confirmed CCCA diagnosis based on a skin biopsy, Stage II or III
- Have had stable hair-loss treatment for at least 3 months (no dose/type changes)
- Examples of stable treatments may include doxycycline, topical steroids, minoxidil, and/or injected (intralesional) steroid treatments
- Only join if your hair loss is only CCCA (not another type) and you have not used a light source for alopecia before
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests an oral medication called deucravacitinib for people with scarring hair loss (frontal fibrosing alopecia or central centrifugal cicatricial alopecia). It aims to see if the drug can reduce inflammation and stop or slow hair loss.
This study tests an oral medication called delgocitinib, which targets certain enzymes linked to inflammation, in people with central centrifugal cicatricial alopecia (CCCA) or lichen planopilaris (LPP). It aims to see if the drug is safe and if it changes biomarkers (biological signals) related to these conditions.
This trial compares platelet-rich plasma (a treatment made from your own blood) to a placebo to see if it helps regrow hair in women with a specific type of scarring hair loss called central centrifugal cicatricial alopecia (CCCA), which often affects women of African descent.
This study looks at treatment results for central centrifugal cicatricial alopecia (CCCA), a type of hair loss that causes scarring and permanent hair loss. It will follow African-American women to see how well treatments work for different levels of severity.
This trial tests if a non-ablative laser can help treat scarring alopecia (a type of hair loss where follicles are replaced by scar tissue). Researchers will also study your hair follicles' genes to understand how the laser works. It may be an option if your hair loss has been stable for at least 3 months.
This trial tests whether minoxidil (a hair-regrowth medication) alone or combined with red-light therapy can help hair grow back after breast cancer chemotherapy. The goal is to help patients recover from chemotherapy-induced hair loss.
Hear when a new Central Centrifugal Cicatricial Alopecia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.